Saturday 17 October 2026
Export PTPI’s income statement to Excel — free account
Petros Pharmaceuticals, Inc.
PTPI Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, revenue grew 1,070.6%, EPS grew 76.7% and free cash flow grew 71.3%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow PTPI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
1.23 | 1.66 | 2.24 | 2.20 | |
Current Ratio |
1.25 | 1.68 | 2.25 | 2.22 | |
Net Debt/EBITDA |
3.53 | 4.24 | 13.12 | 6.13 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.06 | 0.79 | 0.54 | 0.98 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.02) | (0.02) | (0.03) | (0.03) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.02) | (0.02) | (0.03) | (0.03) | |
Cash per Share |
0.07 | 0.09 | 0.18 | 0.14 | |
Shareholders Equity per Share |
0.01 | 0.04 | 0.10 | 0.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.01 | 0.04 | 0.10 | 0.08 | |
Free Cash Flow |
(0.86) | (0.78) | (0.93) | (1.13) | |
Working Capital |
0.70 | 1.77 | 2.87 | 3.37 | |
Net Current Asset Value |
0.70 | 1.77 | 2.87 | 3.37 | |
| Other line items | |||||
Average Payables |
0.53 | 0.45 | 0.42 | 1.01 | |
Average Assets |
5.47 | 11.00 | 7.90 | 13.41 | |
Average Common Equity |
2.57 | (3.91) | (2.30) | 3.24 |
Columns are period end dates